Your browser doesn't support javascript.
loading
Physician-Modified Endograft-Facilitated Transcatheter Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract.
Ueyama, Hiroki A; Greenbaum, Adam B; Leshnower, Bradley G; Keeling, Brent; Block, Peter C; Byku, Isida; Ligon, R Allen; Grier, Elizabeth; Shekiladze, Nikoloz; Gleason, Patrick T; Xie, Joe; Kim, Dennis W; Babaliaros, Vasilis C; Duwayri, Yazan.
Affiliation
  • Ueyama HA; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Greenbaum AB; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Leshnower BG; Division of Cardiothoracic Surgery (B.G.L., B.K.), Emory University School of Medicine, Atlanta, GA.
  • Keeling B; Division of Cardiothoracic Surgery (B.G.L., B.K.), Emory University School of Medicine, Atlanta, GA.
  • Block PC; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Byku I; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Ligon RA; Division of Cardiology, Children's Healthcare of Atlanta (R.A.L., D.W.K.), Emory University School of Medicine, Atlanta, GA.
  • Grier E; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Shekiladze N; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Gleason PT; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Xie J; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Kim DW; Division of Cardiology, Children's Healthcare of Atlanta (R.A.L., D.W.K.), Emory University School of Medicine, Atlanta, GA.
  • Babaliaros VC; Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, GA (H.A.U., A.B.G., P.C.B., I.B., E.G., N.S., P.T.G., J.X., V.C.B.).
  • Duwayri Y; Division of Vascular and Endovascular Therapy (Y.D.), Emory University School of Medicine, Atlanta, GA.
Circ Cardiovasc Interv ; 16(9): e013123, 2023 09.
Article in En | MEDLINE | ID: mdl-37577788
BACKGROUND: Transcatheter pulmonary valve replacement (TPVR) in patients with a congenital or acquired abnormality resulting in enlarged right ventricular outflow tract (RVOT) is challenging and may preclude treatment with dedicated devices. We describe a technique using a physician-modified endograft to facilitate TPVR. METHODS: Six patients underwent physician-modified endograft-facilitated TPVR for severe symptomatic pulmonary insufficiency with enlarged RVOT. The fenestration was created in a commercially available endograft before implantation, which was then deployed from the dominant branch pulmonary artery into the RVOT, with the fenestration aligned with the ostium of the nondominant pulmonary artery. A covered stent was placed through the fenestration into the nondominant branch pulmonary artery, and a transcatheter heart valve was deployed within the endograft at the level of the original pulmonary valve. RESULTS: Four patients had tetralogy of Fallot, 1 had pulmonary atresia, and 1 had rheumatic valve disease. The RVOT/main pulmonary artery was severely enlarged (diameter, 44.2 [43.5-50.6] mm). All patients had reduced right ventricular (RV) function and dilated RVs (RV end-diastolic volume, 314 [235-316] mL). Successful endograft, covered stent, and transcatheter heart valve deployment were achieved in all cases without stent/valve embolization, vascular complications, or bleeding complications. At 30 days, 1 patient had mild pulmonary insufficiency, while others had none. The RV size measured by echocardiography was significantly reduced after TPVR (RV area, 34.4 [baseline] versus 29.0 [pre-discharge] versus 25.3 [30 days] cm2; P=0.03). During median follow-up of 221.5 (range, 29-652) days, there were no deaths or need for pulmonary valve reintervention. One patient developed severe tricuspid regurgitation due to entrapment of the anterior tricuspid leaflet by the endograft. The patient underwent successful tricuspid replacement and resection of the offending endograft with preservation of the pulmonary valve prosthesis. CONCLUSIONS: Simple fenestration of an off-the-shelf endograft and associated covered stent placement through the fenestration allows TPVR for patients with dysfunctional native or patch-repaired pulmonary valves and RVOT enlargement.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Valve / Pulmonary Valve Insufficiency / Heart Valve Prosthesis / Heart Valve Prosthesis Implantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Valve / Pulmonary Valve Insufficiency / Heart Valve Prosthesis / Heart Valve Prosthesis Implantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article Country of publication: